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The information encoded in the genome comprises 
genes, the protein products of which mediate most 
of the functions in organisms, and control elements1. 
Proteins were thought to be the most important effec-
tors in the cells, although recently non-coding RNAs 
have also been identified as important players in 
regulatory processes2. Proteins and RNAs rarely func-
tion alone, but rather in complexes or in networks. 
In addition, genomic control elements contribute to 
gene-regulatory networks.
The regulation of biological processes depends on 
multiple parameters of a pathway. Many complex dis-
eases can be regarded as perturbations at one of many 
points on a pathway that controls a normal, function-
ally intact biological process3. Therefore, real progress 
in diagnosis and therapy of many common diseases 
will require the identification and detailed analysis of 
many and possibly all components of these complex 
biological processes.
Large data sets, comprising functional genomics, pro-
teomics and metabolomics data, as well as biochemical 
information, provide the basis for SYSTEMS BIOLOGY4. Most 
of these data are still being generated in vitro, although 
in vivo data will have an increasingly important role in 
the future. Integration and handling of these many data 
types through modelling will be the only way to convert 
our current knowledge into a predictive capability for 
improving the therapy of many complex diseases1,4.
Cost-effective generation of data using large num-
bers of samples, analysis of limited amounts of biological 
material and handling of intrinsic biological heterogene-
ity will be necessary for this systems biology approach, 
and can be achieved through parallelization and mini-
aturization of biological assays. The parallelization of 
oligonucleotide hybridization assays was a key step in 
the development of genome-wide technologies5–8 (FIG. 
1). Recently, protein array formats have been used and 
will certainly improve the parallel analysis of proteins9,10. 
Miniaturization can complement these developments 
by reducing the volume and increasing the density of 
assays. It can also help when analysing larger numbers 
of samples in parallel. The scale of natural substrates that 
can be analysed BOX 1 and various molecular biological 
devices are summarized in TABLE 1. The ultimate goal 
of miniaturization involves analysis of smaller, more 
homogeneous sections of complex samples, reduction 
of costs and preservation of precious samples.
In this article, we will mainly discuss a selection 
of miniaturized in vitro and in situ procedures for the 
parallel, sensitive and discrete analysis of nucleic acids 
and proteins.
Reducing complexity
Techniques such as cell sorting11, manual dissec-
tion12 and LASER CAPTURE MICRODISSECTION (LCM)13 have 
been used to isolate homogeneous cell samples, an 
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Abstract | Proteins are the key components of the cellular machinery responsible for 
processing changes that are ordered by genomic information. Analysis of most human 
proteins and nucleic acids is important in order to decode the complex networks that are 
likely to underlie many common diseases. Significant improvements in current technology 
are also required to dissect the regulatory processes in high-throughtput and with low 
cost. Miniaturization of biological assays is an important prerequisite to achieve these 
goals in the near future.
SYSTEMS BIOLOGY 
The study of the complex 
interactions that occur at all 
levels of biological information 
— from whole-genome 
sequence interactions to 
developmental and biochemical 
networks — and their 
functional relationship to 
organism-level phenotypes. 
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0.25–1nl of DNA solution is 
printed on a slide, creating
spots that range from 
100 to 150 µm in diameter
A typical fluorescent 
read-out of highly 
parallel hybridization
on a cDNA microarray
LASER CAPTURE 
MICRODISSECTION 
A method in which cells 
are cut out from a tissue 
sample using a laser beam. 
CELL FRACTIONATION 
Separation of cells by size, 
weight, density, and optical 
and bioelectrical properties.
MONOLITHIC SUBSTRATES
A substrate made from silicon 
or polymers that allows 
microfabrication of planar 
fluidic devices that have 
integrated microchannels or 
functional elements such as 
electrodes and detectors.
important prerequisite in many biological studies. 
However, even cells of the same type usually repre-
sent different stages of physiological processes. The 
complexity of biological material is currently also 
reduced by applying labour-intensive biochemical 
CELL FRACTIONATION and subcellular isolation steps 
before carrying out the analysis of a set of molecules 
or single molecules14. 
Amplification techniques such as PCR have suc-
ceeded in reducing the amount of sample needed12 
and concomitantly reducing the complexity of 
genomic DNA. Although PCR can be used to amplify 
small numbers of DNA molecules in low microlitre 
or nanolitre volumes in vitro, problems are associated 
with the dilution of heterozygous DNA. This could 
result in incorrect genotyping results (homozygous 
genotypes) because of the preferential amplification of 
one of the alleles. Extreme dilution indicates that there 
is a sufficiently high integrity of the nucleic-acid tem-
plates to allow efficient amplification. Furthermore, 
amplification of low concentrations of nucleic acids 
requires strict quality control, as it is often associated 
with contamination problems, which can be problem-
atic in high-throughput applications. In contrast to 
nucleic-acid manipulation, it is currently impossible 
to amplify proteins from a biological sample.
Miniaturization in functional genomics
Genome research and functional genomics have cata-
lysed the development of high-throughput and minia-
turized approaches for the analysis of biomolecules5–8.
Figure 1 | DNA micorarrays. DNA microarrays that are based on non-porous solid 
supports such as glass have paved the way for highly parallel miniaturized analysis of 
biomolecules. Using robotic workstations, ~0.25–1 nl of DNA solution are printed on a 
slide, creating spots that range from 100 to 150 µm in diameter. Successive samples are 
then spaced to avoid contact between adjacent spots, with approximately 200 µm 
between each spot7. Currently, about 50,000 cDNAs can be robotically spotted onto a 
microscope slide and hybridized with a fluorescently labelled probe. Using 
photolithographical masking techniques, arrays that have 400,000 distinct 
oligonucleotides have been produced, each in its own 20-µm2 region (today, this can be 
as small as ~5 µm2) REF. 8. After spotting, nucleic-acid samples can be hybridized on 
these pre-structured microarrays. Hybridization events are monitored using fluorescence 
scanners. A typical fluorescence read-out of highly parallel hybridization on a cDNA 
microarray is shown in the bottom panel.
Box 1 | Technological problems in miniaturization 
Every molecular biological method can be miniaturized from microlitre to nanolitre volumes, or from molecules in 
the micromolar range down to single molecules (the low zeptomole range). However, miniaturization of biological 
assays is more complex than just transferring reactions to smaller volumes122. The surface to volume ratio becomes 
higher through miniaturization, making surface treatment important in preventing non-specific binding of 
components to the system walls. Formats that have a quasi-spherical shape, such as droplets, offer the best (lowest 
possible) surface to volume ratio, as they reduce contact with other surfaces. Further problems include the sticking 
of biomolecules, such as DNA or proteins, to the system wall, and even shearing of these molecules. The main 
structured substrate types in miniaturization comprise microarrays, nanowell plates, microchannels, 
nanomembranes and nanocapsules123. Here, we focus on problems with microcapillary devices (microchannels) 
that are formed in MONOLITHIC SUBSTRATES. In these capillaries, which are normally 10–50 µm deep and 10–400 µm 
wide, increased flow resistance for pressured liquid flows is observed. Problems caused by the interfaces between 
pumps and capillaries124 can be overcome with the use of electrokinetics, which applies electrical fields instead of 
using pumps and valves. Flow rates of microfluidic systems require suitable compound-mixing procedures. Also, by 
reducing the volume of an assay, the influence of small molecular differences increases. Reactions within small 
volumes will be limited by the diffusion of the components (diffusion limit). This problem can be overcome by 
active mixing of the liquid; for example, by surface acoustic waves125. The important issues in applying miniaturized 
assays include the degree of integration of hardware components and the degree of automation that is achievable. 
Droplets that contain less than 100 nl of liquid can be effectively dispensed by nanoliquid handling. A decrease from 
10 nl down to 50 pl can be achieved using piezopipetting systems. About 100-fl resolution is possible with bubble-jet 
dispensing methods. However, mainly owing to lack of integration, these potentially powerful devices are still being 
applied manually or with low throughput.
Microfluidic devices have mainly been used for single-step analysis122. Multiple-step analysis can be performed by 
‘lab-on-a-chip’ devices that allow the integration of pumps, valves and channels on a chip. Multiple operations such 
as cell sorting, DNA purification and single-cell expression analysis can be carried out simultaneously126,127. 
Interfaces between microfluidic arrays and electrospray ionization mass spectrometers have been developed for 
protein analysis128,129. Protein identification could be achieved by using immobilized trypsin gel beads, integrated 
into an electro-osmotic flow system that is coupled with mass spectrometric detection130,131.
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MICROSATELLITE 
A class of repetitive DNA 
sequences that are made up of 
tandemly organized repeats 
that are 2–8 nucleotides in 
length. They can be highly 
polymorphic and are frequently 
used as molecular markers in 
population genetics studies. 
DNA MICROARRAY 
An array of PCR products 
or oligonucleotides 
(corresponding to either 
genomic or cDNA sequences) 
that are deposited on solid 
glass slides and can be used to 
interrogate complex nucleic-
acid samples by hybridization. 
High-throughput methods to investigate DNA variation. 
Mutations can significantly influence protein function 
and disease predisposition. Chromosomal imbal-
ances have for a long time been studied by com-
parative genome hybridization (CGH) of metaphase 
chromosomes15. More recently, matrix CGH15, in 
which chromosome targets are replaced by an 
ordered set of specific nucleic-acid target sequences 
on a microarray, has been introduced as a diagnostic 
tool to analyse genomic alterations at a higher reso-
lution; for example, to detect changes in gene copy 
number.
SNPs16 and polymorphic MICROSATELLITES17 can be 
used as genetic markers for genomic regions that are 
associated or linked to a specific trait or a common 
disease. Genome-wide sequencing would be the most 
straightforward approach to test rare and common 
variants for roles in complex traits18. The ultimate goal 
of sequencing technology is to sequence genomes of 
individual patients and organisms in a reasonable time 
(1 day) and at a low cost (~1,000 euro per human 
genome). Although sequencing procedures such as the 
Sanger method have been refined to a large extent19, 
current costs are still too high to make sequenc-
ing human genomes affordable. Real progress has 
not been made in the past several years, despite the 
development of new approaches, such as using high 
levels of parallelization in sample preparation and 
using DNA MICROARRAYS or capillary devices20. A new 
method that integrates DNA isolation, amplification 
and sequencing makes use of polymerase colonies 
(termed ‘polonies’)21,22. Small amounts of genomic 
DNA are integrated into a polyacrylamide gel contain-
ing PCR reagents that covers a microscope slide. The 
concentration of DNA is low, so that the chromosome 
fragments are efficiently separated before amplifica-
tion and dideoxynucleotide sequencing that is based 
on fluorescence detection. Multiple polonies can be 
sequenced in parallel in situ. However, this method 
would benefit from a higher density of polonies to 
accelerate throughput. Pyrosequencing is an alterna-
tive DNA-sequencing procedure for sequencing short 
stretches of DNA. It is useful for quantifying alleles 
in mixtures of DNA samples, and in small genomic 
regions of high sequence variation23.
Single DNA molecule sequencing approaches 
have also been developed that use nanopores 
consisting of channels with diameters of ~2 nm 
(the diameter of single-stranded nucleic acids) 
embedded, for example, in an Si3N4 membrane
24,25. 
Table 1 | Dimensional scaling of miniaturized systems in genomics and proteomics 
Scale Volume relation 
(calculated to a cube)
Classification Examples of samples and substrates
100 mm 1 l = (100 mm)³ Macrostructures The size of standard microplates with 96 to 1536 
wells is 128 mm x 86 mm. The size of a standard 
microscopic slide is 75 mm x 25 mm. 
10 mm 1 ml = (10 mm)³ – The well distance in standard microplates is 9 mm, 
4.5 mm or 2.25 mm. 
1 mm 1 µl = (1 mm)³ – This is the thickness of a standard microscopic 
slide. The spot distance of printed slides is 
approximately 0.2–0.9 mm. 
100 µm 1 nl = (100 µm)³ Microstructures The size of nanowells and microchannels is in the 
range of 50–500 µm. The diameter of the orifice of 
dispensing nozzles is approximately 50–100 µm. 
The typical inner diameter of microcapillaries for 
electrophoresis is 20–100 µm. 
10 µm 1 pl = (10 µm)³ – Cells have a diameter of approximately 10 µm. 
Photolithographic array structures have a dimension 
of 5–20 µm. 
1 µm 1 fl = (1 µm)³ – The wavelength of visible light is in the range of 
0.4–0.7 µm. The wavelength for near infrared 
light is 1 µm. In ESI MS, the spraying orifice has a 
diameter of 1–2 µm. 
100 nm n/a Nanostructures This is the approximate size of viruses. The typical 
pore diameter of nanoporous membranes in metal 
is 20–100 nm. 
10 nm n/a – This is the approximate size of macromolecules. 
The typical diameter of quantum dots (nanocrystals) 
is 2–10 nm REF. 141, which is the detection range 
of atomic-force microscopy. 
1 nm n/a – This is the approximate size of molecules. The 
average diameter of carbon nanotubes is 1–2 nm 
REF. 142. The diameter of nanochannels for DNA 
sequencing is 2 nm. 
100 pm n/a Subnanostructures This is the approximate size of atoms.
ESI MS, electrospray ionization mass spectrometry.
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MASS SPECTROMETRY 
An analytical technique for the 
determination of molecular 
mass. Although they vary 
greatly in design, all mass 
spectrometers share three 
general components: an ion 
source in which gas-phase 
molecular ions are produced 
from the analyte molecules, a 
mass analyser in which electrical 
and/or magnetic fields are used 
to separate the analyte ions by 
their different mass-to-charge 
(m/z) ratios and a detector for 
recording the separated ions. 
HAPLOTYPE 
The combination of alleles or 
genetic markers that is found 
on a single chromosome 
of a given individual. 
ROLLINGCIRCLE 
AMPLIFICATION 
A mode of DNA replication 
used by circular DNAs, which 
generates molecules that 
look similar to lariats. It was 
traditionally associated with 
certain bacterial plasmids and 
viruses, but is increasingly 
used as an alternative method 
for DNA amplification. 
Unfortunately, parallelization and the production of 
robust membranes are important problems that need 
to be solved before these approaches can be applied.
Powerful methods for high-throughput SNP typ-
ing have recently been developed. They are based on 
the parallel generation of products that contain up to 
~100,000 SNPs (this will probably increase to 1,000,000 
in the next 2 years) in patient DNA, which lie in the 
microlitre range. These products are subsequently ana-
lysed by fluorescence analysis on DNA microarrays26,27 
or bead-based arrays28. Such procedures are particu-
larly useful for whole-genome scans or when several 
thousand SNPs have to be simultaneously genotyped 
for large-scale approaches such as the International 
HapMap Project29. 5´ Nuclease (TaqMan) assays30 and 
miniaturized MASS SPECTROMETRY procedures31–34 are 
commonly used for genotyping up to ~100 SNPs per 
genome in more than ~1,000 DNA samples in candidate 
gene studies. Furthermore, mass spectrometry can be 
used in the multiplex molecular analysis of HAPLOTYPES 
using template-DNA dilution and single-molecule 
amplification35, allele-specific PCR36 or a clone-pooling 
approach37. The first two procedures are more useful 
for haplotyping short stretches of the genome in large 
DNA cohorts, whereas the last one is more powerful 
for analysing many genes or large genomic regions in 
a small cohort.
Recently, Landegren and co-workers have intro-
duced a highly specific in situ SNP genotyping 
method, which makes use of allele-specific ligation 
of single oligonucleotide ligation probes (padlock 
probes) and ROLLINGCIRCLE AMPLIFICATION (RCA)38. This 
approach can detect single nucleotide position dif-
ferences between individual nucleic acids and it has 
been used to characterize genetic variation in mito-
chondrial genomes38. As this method can efficiently 
discriminate pools of only slightly diverse nucleic 
acids, it can be used for the diagnosis of bacterial 
RNA in biological or clinical samples.
The systematic and sensitive analysis of DNA 
methylation is important for understanding regula-
tion at the DNA level39,40. Analysis of genomic DNA 
that is treated with bisulphite, in which the non-
methylated cytosines are converted to uracil while 
the methylated cytosines remain stable, is a common 
procedure for determining methylation patterns in 
chromosomal DNA41. High levels of sensitivity can 
be achieved through bisulphite treatment and sub-
sequent PCR performed on material embedded in 
agarose beads41. Using this procedure, sequences of 
single-copy genes that are amplified from as little as 50 
pg of bisulphite-modified chromosomal DNA, which 
is equivalent to about 10 individual cells, can be ana-
lysed with good reproducibility41–43. Again, sensitivity 
is crucial here, as the amount of samples, especially in 
clinical diagnosis, is limited. A relevant application 
in this respect is the specific methylation profiling of 
gene promoters that are used for early-stage diagnosis 
of diseases such as cancer.
New RNA-based approaches to monitoring gene 
expression. Currently, one of the most frequently 
applied methods for studying biological networks is 
the comprehensive investigation of RNA expression 
in a cell. Expression profiles of healthy and cancerous 
cells can reveal meaningful changes, provide diagnostic 
markers and indicate potential new drug targets44,45. The 
identification of non-coding RNAs as key players in 
various regulatory processes indicates that such RNAs 
might regulate one third of human genes2,46. A detailed 
identification of these components and their role in 
regulatory networks could constitute a great challenge 
in itself.
RNA-expression analysis mainly builds on DNA 
microarrays47, using TILING OLIGONUCLEOTIDE MICROARRAYS. 
However, the specificity of such microarrays with regard 
to allele-specific and splice-variant-specific expression 
profiles and the quantification capability of RNA expres-
sion is poor. Massively parallel signature sequencing 
(MPSS) is a new array-based technology for in-depth 
gene-expression profiling48. This technology combines 
non-gel-based sequencing of short ‘signature’ sequences 
with the cloning of millions of DNA templates on 
microbeads. A planar array of at least a million of these 
microbeads is assembled in a flow cell at a density of 
roughly several million microbeads per cm2. DNA 
sequences at the free ends of the cloned templates are 
simultaneously analysed by applying a fluorescence-
based signature-sequencing method. Even a few mRNAs 
per cell can be routinely detected by this method.
Approaches to precisely monitoring gene expres-
sion at a notably reduced cost, and at a higher 
throughput, would significantly accelerate RNA 
Figure 2 | Nanowell plates. a | Nanodispensing provides contact-free distribution of nanolitre 
droplets on nanowell plates (and microfluidic chips) without disturbing or changing the surface 
properties. The deposition of a nanodroplet grid onto a glass surface is carried out using the 
multichannel print head TopSpot (IMTEK). The volume of the droplet is 1 nl. Ninety-six droplets 
are arrayed in a 4 × 24 format. The print head, which has microchannels for liquid transport 
from reservoirs to the nozzles, is placed at a 500-µm distance above a glass substrate in the 
dispensing regime. The print head is connected to a precise positioning table (400 × 400 mm²) 
to allow serial dispensing in requested positions and it can be adjusted in all directions and 
angles. The dispensing procedure is monitored with a camera from the bottom of a transparent 
plate. b | In high-density nanowell plates, the distance between neighbouring nanowells is 
500 µm in order to achieve an exact overlapping with the nozzle grid of the TopSpot print head. 
Nanowell plates that have well diameters of 100−500 µm and volumes of about 1–100 nl can 
be designed to separate samples and reduce evaporation139. In this figure, the wells at the top 
are filled with 1-nl droplets, the wells in the middle are filled with 4-nl droplets, and the wells at 
the bottom are filled with 8-nl droplets. Nanowell plates are made of silicon elastomers such as 
polymethylsiloxane, or are etched on glass slides. Nanowell chips are well-suited for 
miniaturized protein assays. Cell-free transcription and translation of proteins can be carried 
out using piezoelectrical dispensers to transfer proteins into wells, down to volumes of 100 nl, 
and fluorescence can be detected using a LASER SCANNING CONFOCAL MICROSCOPE140.
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TILING OLIGONUCLEOTIDE 
MICROARRAYS 
These microarrays contain 
a set of overlapping 
oligonucleotides that span 
either the entire genome, or 
for a more specialized approach, 
a subregion of interest. 
LASER SCANNING 
CONFOCAL MICROSCOPE 
A light microscope that allows 
imaging of fluorescent 
structures in thick (tens to 
hundreds of micrometres) 
specimens. A series of optical 
‘slices’ are collected using a 
scanning laser beam and 
specially designed optics to 
eliminate out-of-focus excited 
fluorescence. The slices are 
reconstructed to provide 
detailed three-dimensional 
representations of the image 
data. 
XRAY CRYSTALLOGRAPHY 
The study of the molecular 
structure of crystalline 
compounds through X-ray 
diffraction techniques. When 
an X-ray beam bombards a 
crystal, the atomic structure of 
the crystal causes the beam to 
scatter (diffract) in a specific 
pattern. X-ray crystallography 
provides information on the 
positions of individual atoms 
in the crystal, the distances 
between them, the angles of 
the atomic bonds and other 
features of molecular geometry. 
CRYOELECTRON MICROSCOPY 
Specimens are quick-frozen 
by plunging them into liquid 
ethane and are then kept 
frozen throughout the imaging 
process. Rapid freezing causes 
the water to form vitreous ice 
around the sample, preserving 
its native structure. Analysis 
of the structure can then 
be carried out in this state 
by electron microscopy.
expression profiling studies. However, sensitivity 
is a crucial factor here, particularly because of the 
restricted amounts of starting materials, such as 
clinical samples. This problem can be solved by using 
circularizable oligonucleotide probes combined with 
RCA of these probes49. Alternatively, accurate and 
quantitative real-time reverse-transcription PCR, 
which is mainly used to validate microarray data50, 
can be used cost effectively on nanowell plates (FIG. 2). 
New instruments that allow an efficient combination 
of liquid handling with nanowells and microfluidics 
are currently under development.
High-throughput functional characterization of 
genes can be carried out on a cell-wide level using 
transfected-cell microarrays51. Full-length genes 
cloned in expression vectors are spotted onto a glass 
slide with a lipid transfection reagent using an arrayer. 
The glass slides are covered with a layer of adherent 
cells. Only the cells that grow on top of the DNA spots 
can be transfected, so that specific genes are expressed 
in spatially distinct groups of cells. The phenotypic 
results of this ‘reverse transfection’ of thousands of 
genes can be analysed using specific cell-based assays. 
This approach has frequently been applied for using 
small interfering RNAs to silence genes52. Some of 
the limitations of this method include the cationic 
transfection agent used, which restricts application 
to a particular subset of cell types, and the difficul-
ties in long-term storage of small interfering RNA 
microarrays.
Miniaturized technologies in proteomics
The systematic study of protein structures, post-
translational modifications, protein profiles, protein–
protein, protein–nucleic acid and protein–small 
molecule interactions, and the spatial and temporal 
expression of proteins in eukaryotic cells are crucial to 
understanding complex biological phenomena. Here, 
we describe a selection of techniques that we consider 
particularly useful or promising for the functional 
analysis of proteins.
Structural genomics. The ultimate goal of structural 
genomics is to determine the structure of almost all the 
proteins in a cell or an organism. Three-dimensional 
structures are important for the functional analysis of 
proteins in a cell and for rational drug design53. In prin-
ciple, databases of genome sequences allow cloning, 
expression and purification of all encoded proteins. 
DNA-cloning procedures and cDNA-clone resources, 
generated during the human genome sequencing era, 
allow at least the semi-automatic large-scale produc-
tion of proteins54. Automation of sample-purification 
methods significantly increased the high-throughput 
production of proteins. In addition, miniaturized pro-
cedures for the crystallization of proteins in 1,536-well 
formats or in capillaries have significantly accelerated 
X-ray structure analyses.
At present, it seems difficult to determine the struc-
ture of all the proteins in a cell or organism in order 
to understand protein function and protein–protein 
interactions at the molecular level. The number of 
different protein variants that are due to alternative 
splicing and/or post-translational modifications is 
significantly greater than the number of genes in the 
human genome. Another problem is associated with 
the preparation of proteins for X-ray structure analysis. 
According to the Ensembl database, 22% of the pro-
teins encoded in the human genome have at least one 
hydrophobic transmembrane domain, and this poses 
particular challenges for expression and analysis by 
XRAY CRYSTALLOGRAPHY or nuclear magnetic resonance 
(NMR)55. In addition, in our hands, some muscle pro-
teins (titins) are difficult to detect due to their large 
size and because of solubility problems. However, these 
problems do not only affect structural analysis; they 
also influence many other aspects of protein analysis, 
as described in the next sections.
CRYOELECTRON MICROSCOPY has greatly improved our 
understanding of the structure and function of large 
native protein complexes, especially in the fields of 
translation, viral fusion and protein folding. It 
has been used for single-particle analysis or for 
cryo-tomography of cell organelles and protein com-
plexes56,57; techniques that have improved dramatically 
in terms of automated data acquisition and process-
ing58. One of the rate-limiting steps in single-particle 
analysis involves the preparation of structurally homo-
geneous samples. This is a great challenge as protein 
complexes can be structurally heterogeneous owing 
to the variety of post-translational modifications and 
binding partners. The lack of technology for such com-
plex analysis is still a hurdle to truly high-throughput 
experiments in this area. X-ray structure analysis and 
cryo-electron microscopy are highly complemen-
tary techniques, and the mapping of high-resolution 
X-ray maps onto cryo-electron microscopy images will 
provide detailed information both on atomic and also 
macromolecular assemblies.
Post-translational modifications and protein profiles. 
Mass spectrometry in combination with chroma-
tographic or electrophoretic separation techniques 
is currently the method of choice for identifying 
endogenous proteins in cells, characterizing post-
translational modifications and determining protein 
abundance59.
Two-dimensional gel electrophoresis is unique 
with respect to the large number of proteins (>10,000) 
that can be separated and visualized in a single experi-
ment60. Protein spots are cut from the gel, followed by 
proteolytic digestion, and proteins are then identified 
using mass spectrometry61. Differential fluorescence 
labelling techniques have improved the accuracy 
of quantitative comparisons of protein abundance 
between samples62. However, standardization and 
automation of two-dimensional gel electrophoresis 
has proved difficult and the use of the resulting protein 
patterns as proteomic reference maps has only been 
successful in a few cases. A complementary technique, 
liquid chromatography, is easier to automate, and 
it can be directly coupled to mass spectrometry63,64. 
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c
Parallel expression and purification 
of prey proteins with an affinity 
tag (RGS (His)6-tag)
Immobilization on 
modified glass slides
Affinity tag
Glass slide
Affinity tag
Glass slide
Prey proteins
Prey proteins
Bait proteins
Detection of immobilized proteins 
with an anti-RGS (His)6 antibody
Detection of protein–protein 
interactions with a specific 
antibody against the bait protein
96-well plates
MATRIXASSISTED LASER 
DESORPTION/IONIZATION 
MASS SPECTROMETRY
(MALDI MS). An ionization 
technique that is suitable for 
mass spectrometric analysis of 
large biomolecules. Samples are 
prepared by embedding analyte 
molecules in a condensed 
matrix of small molecules. A 
brief laser pulse irradiates a 
spot on the sample, resulting 
in ablation of a small volume of 
the matrix and desorption of the 
embedded analyte molecules. 
Analyte molecules are then 
ionized, which leads to the 
formation of predominantly 
singly charged positive and 
negative analyte ions. 
Minimized surface areas of nanoliquid chromato-
graphical systems reduce analyte losses due to surface 
adsorption and dead volumes (the amount of overfill 
left in the tubing after dispensing is complete). The 
resolving power necessary for isolation of proteins 
and peptides can often be achieved by coupling two or 
more chromatographical separation modes in series. 
However, this is at the cost of increased analysis times, 
analyte recovery and reproducibility.
Methods that are based on stable-isotope labelling 
of proteins and peptides allow (relative) quantitative 
analysis through mass spectrometry with high accu-
racy65. Numerous schemes for using stable-isotope 
labelling have been devised, either in combination with 
affinity tagging to reduce the complexity of proteomic 
extracts66, or in conjunction with systemic perturbations 
of cultured cells to monitor the resulting alterations in 
protein abundance67.
In microbiology, MATRIXASSISTED LASER DESORPTION/
IONIZATION MASS SPECTROMETRY (MALDI MS) can be used 
to analyse samples from whole viruses, bacteria and 
spores68. Although the mass spectra acquired from 
such samples are complex, a characteristic fingerprint 
can be created for each microorganism. In terms of 
clinical relevance, MALDI MS might be applied to 
detect biomarkers for the taxonomic identification of 
bacteria. Protein profiles detected by mass spectrom-
etry represent new diagnostic approaches that can be 
applied, for example, to detect various stages of cancer, 
as cancer cells show different antigen-expression profiles 
to those seen in normal cells69,70. 
Protein–protein interactions. Affinity-based proteomic 
methods that are based on arrays are an alternative 
approach for protein profiling and can also be used 
to detect protein–protein interactions71. Low-density 
antibody microarrays, also known as analytical micro-
arrays, have been developed to monitor the levels of 
marker proteins in blood and sera. Microarrays with up 
to 146 antibodies have been used to detect expression 
changes in LoVo colon carcinoma cells that are treated 
with ionizing radiation72. This procedure has revealed 
upregulation of apoptotic regulators induced by radia-
tion and simultaneous downregulation of the carcino-
embryonic antigen, a prototypic cancer biomarker. 
Recently, we analysed sera from autoimmune patients 
using dense protein microarrays73. By comparing the 
pattern from patients with autoimmune disease versus 
healthy controls, several new antibody–autoantigen 
pairs were identified.
Functional microarrays are used to examine the 
function of uncharacterized proteins (FIG. 3). Because 
there are ~25,000 human genes, and even more pro-
teins, at least 25,000 arrays spotted with 25,000 proteins 
would have to be screened in the search for all possible 
interactions. Database information can help to decrease 
the number of proteins to be studied for interactions on 
functional microarrays74. This information, combined 
with bioinformatic tools, can significantly reduce the 
amount of in vitro screening by in silico prediction of 
biomolecule interactions. 
A remaining problem in the application of protein 
microarrays is binding specificity75,76, because cross-
reactivity cannot accurately be predicted. Furthermore, 
the optimization of surface chemistry, spotting pro-
cedures, and buffer and storage conditions are still an 
important issue in protein microarray development77. 
In addition, none of the currently used methods allow 
the quantitative detection of binding proteins, and it 
remains unclear to what extent the observed interac-
tions are likely to represent physiological protein–protein 
interactions. Such information, however, is essential 
for algorithmic modelling of biological pathways. 
Detailed discussions of state-of-the-art protein arrays 
are provided in the articles by Seong and Choi74, and 
by Espina et al.78.
Procedures such as YEAST TWOHYBRID Y2H ASSAYS79–81 
and TANDEM AFFINITY PURIFICATION (TAP)82–84 are comple-
mentary, powerful large-scale approaches for detect-
ing protein–protein interactions in vivo. However, 
although the Y2H technology has been automated 
Figure 3 | Protein microarrays. a | Detecting protein–protein interactions using protein 
microarrays. Proteins from a ‘prey’ library (white) are expressed and affinity-purified under 
native conditions in a 96-well format. The purified proteins are spotted onto modified glass 
slides. Immobilized proteins can be visualized and quantified using an antibody that is directed 
against the affinity tag (beige). Alternatively, prey proteins can be incubated with a putative 
interaction partner (‘bait’ protein; green). After several washing steps, interactions between the 
bait protein and immobilized prey proteins can be detected by using a specific antibody that is 
directed against the bait protein. b | Detection of approximately 384 different (His)6 (a histidine 
tag consisting of 6 amino acids)-tagged human prey proteins with an anti-RGS (His)6 antibody. 
All proteins were spotted in triplicates. The signal intensity reflects the varying concentration of 
the spotted proteins. c | Visualization of putative interaction partners on a protein microarray 
that consists of 384 (His)6-tagged proteins. The putative interaction partners were detected 
with anti-GST antibodies. White spots in b and c are protein spots that show fluorescence 
intensities that are greater than the dynamic range used.
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Cross-link protein to DNA
Harvest and lyse cells
Sonicate to fragment DNA
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Purify and label DNA
Hybridize to microarray
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Protein
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YEAST TWOHYBRID Y2H 
ASSAY 
One protein is fused to a 
transcriptional activation 
domain (the GAL4 activation 
domain) and the other to a 
DNA-binding domain (the 
GAL4 DNA-binding domain), 
and both fusion proteins 
are introduced into 
yeast. Expression of a 
(GAL4-regulated) reporter 
gene with the appropriate 
DNA-binding sites upstream 
of the promoter indicates that 
the two proteins physically 
interact.  
and widely applied85, the relatively new TAP technol-
ogy remains to be developed, especially in the field of 
mammalian complex analysis. It has been shown that 
up to 50% of the interactions detected by Y2H can be 
false positives, which might be explained by interac-
tions between proteins that do not occur in vivo71. As 
for Y2H, some comparative studies have shown that 
the data that are generated by the TAP method can also 
produce false-positive results; however, this occurs to a 
lesser extent (below 50%)86.
Protein–DNA interactions. Several in vitro meth-
ods for detecting protein–DNA interactions have 
been established, including ELECTROMOBILITY SHIFT 
ASSAYS, ENZYMELINKED IMMUNOSORBENT ASSAY (ELISA)-
based methods or phage-display approaches, which 
have led to the identification of several interaction 
partners for one target87. Phage display has emerged 
as a powerful tool for selecting a protein that recog-
nizes the DNA target from among millions of protein 
variants88. However, such in vitro selection methods 
are time consuming, have a limited throughput and 
often only the strongest interaction is selected. These 
problems have led to the development of different 
microarray approaches that allow high-throughput 
analysis.
One of the first studies to develop different micro-
array approaches described a universal protein-array 
system to study protein–DNA interactions89. This 
system, using 48 different proteins, has been applied 
to investigating the interaction of several promoter–
operator regions with various regulatory proteins89–91. 
Recently, Snyder and co-workers used dense protein 
microarrays that contain nearly all the yeast proteins 
to identify dsDNA and ssDNA binding proteins92. This 
approach revealed several novel proteins that have 
DNA-binding activity and also led to the identifica-
tion of a metabolic enzyme that directly regulates gene 
expression92.
A second approach to studying protein–DNA inter-
actions was developed by Church and co-workers, who 
created dsDNA arrays by enzymatically converting 
ssDNA arrays93. This approach was used to explore 
the DNA-binding specificities of different transcrip-
tion factors at a genome- and proteome-wide level. So 
far, this method yields comparable results to the clas-
sical electromobility shift assays, although at a much 
higher throughput94,95. Apart from identifying known 
binding sites, several putative new target regions were 
identified96. Preliminary experiments using prokaryo-
tic DNA-binding proteins in our laboratory show that 
identical protein–DNA complexes are identified by 
using protein or dsDNA microarrays (Claus Hultschig 
and H.S., unpublished observation). DNA microar-
rays are effectively employed for screening nuclear cell 
extracts for DNA-binding complexes, whereas protein 
microarrays are mainly used for identifying unknown 
DNA-binding proteins on a proteome-wide level. We 
expect that these two techniques will reveal detailed 
insights into transcriptional regulatory networks in 
the future.
The new ChIP-chip technique allows the identifi-
cation of protein–DNA interactions in vivo (FIG. 4). It 
combines chromatin immunoprecipitation (ChIP) 
with DNA microarray (chip) detection97. Originally 
developed to study protein–DNA interactions in 
yeast, this technique was rapidly adopted to eukary-
otic cell lines and tissue samples. The procedure 
requires the optimization of several experimental 
steps, including conditions for cross-linking DNA-
binding proteins to their target regions and for 
sonification to obtain DNA fragments of roughly 
homogenous lengths. ChIP-chip depends on the 
accessibility of at least two resources; first, a set of 
highly specific antibodies that are directed against 
the proteins of interest and second, a DNA microar-
ray that contains the entire genome of an organism, 
or at least all the intergenic regions. 
Figure 4 | Identification of protein–DNA interactions using the ChIP-chip approach. 
Transcription factors are cross-linked in vivo to their binding sites, sonicated and DNA 
fragments that are covalently bound to a transcription factor are enriched and purified by 
immunoprecipitation. The isolated DNA is subsequently tagged by fluorescence labels and 
hybridized on a DNA microarray, thereby allowing the identification of genomic regulatory DNA 
elements. Control experiments are carried out to detect non-specific background.
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TANDEM AFFINITY 
PURIFICATION 
A method that uses the 
expression of fusion proteins in 
cells carrying a double tag that 
is applied in two consecutive 
steps of purification. This 
protocol has the benefit of high 
levels of purification and native 
protein elution for subsequent 
functional, structural or 
biochemical analysis.
ELECTROMOBILITY
SHIFT ASSAY 
An assay in which proteins 
that bind to a DNA fragment 
are detected by virtue of 
their reduced migration 
in an electrical field. The 
assay is often used to detect 
transcription-factor binding. 
Protein–small molecule interactions. The use of 
small chemical compounds and natural products is 
an important step, both for pathway mapping and 
drug discovery98. In principle, microarrays provide 
a platform for parallel and fast interaction screen-
ing, which can be performed with a minimum con-
sumption of compounds, while still giving a high 
signal-to-background ratio. In early attempts, small 
molecules were spotted on microarrays to detect 
binding proteins99. Problems that were associated 
with steric hindrance have now been solved by 
using linkers that are attached to the small mol-
ecules. Kuruvilla et al. have systematically screened 
3,780 1,3-dioxane compounds to examine the func-
tion of the yeast protein urease β-subunit (Ure2)100. 
The compound that was identified to specifically 
bind the Ure2 protein, uretupamine, is a central 
regulator of the nitrogen metabolic pathway.
A new approach uses soluble small molecules that 
are attached to a PEPTIDE NUCLEIC ACID (PNA) contain-
ing a fluorescent dye101. The PNA encodes a sequence 
that is complementary to a specific oligonucleotide, 
which is spotted on a DNA microarray. Proteins 
are mixed in solution with the PNA-modified small 
molecules, followed by SIZEEXCLUSION CHROMATOGRAPHY 
to separate the different complexes. The protein–small 
molecule complex is hybridized to a DNA microarray 
using a PNA tag, and quantification of the binding 
process is achieved through fluorescent detection. 
This method has been applied to monitoring protease 
activities in crude cell lysates and in blood samples102.
Recently, workers from Novartis Pharma AG have 
developed SpeedScreen, a high throughput proce-
dure for drug discovery that is based on ELECTROSPRAY 
IONIZATION (ESI) mass spectrometry103. This method 
provides direct identification of small molecules that 
bind a protein. Several hundred compounds are mixed 
with a purified protein, followed by size-exclusion 
separation in 96-well formats. The complex is then 
denatured and the binding compound can be accu-
rately determined by its mass. The method was vali-
dated with known protein–ligand complexes and 
optimized for selection of molecules that bind with 
high-affinity. The liquid-handling steps and detec-
tion are robust and widely automated. A minimum 
of tens of thousands of compounds can be screened 
per day on an industrial level, using only one mass 
spectrometer. Further miniaturization of the liquid-
handling steps to lower microlitre volumes could 
reduce the cost-intensive consumption of chemical 
compounds.
Miniaturized enzymatic assays. Protein microarrays 
that are based on microscope slides can be used to test 
enzymatic activities and for pathway mapping and 
substrate identification. For example, Snyder and co-
workers have immobilized a set of yeast proteins with 
predicted kinase activity using nanowell plates104. The 
large-scale analysis of more than 100 kinases allowed 
correlation of functional specificity of kinases with cer-
tain amino-acid sequences104. This approach identified 
novel (in vitro) substrate specificity of kinases and has 
provided new data on enzyme–substrate interactions 
at a molecular level. Recently, we have introduced mul-
tiplex enzymatic assays on microarrays using the mul-
tiple-spotting technology, and we were able to detect 
35 enzyme molecules per spot105. This approach allows 
the rapid screening of thousands of samples on a single 
microarray, which has applications in drug screening 
and high-throughput enzymatics. Extreme sensitivity 
and even higher throughput might be achieved by using 
microfabricated substrates that enable single molecule 
enzymology106. It is likely that the miniaturized high-
throughput enzyme-screening procedures that have 
been mentioned in this article will evolve and become 
mature technologies in the next years.
Protein localization. Systematic protein-localization 
approaches that raise antibodies against large parts of 
the proteome have successfully been used for localiza-
tion and expression analysis107. Although this method 
provides high spatial resolution and sensitive detec-
tion of target proteins, it precludes the analysis of the 
dynamics of protein transport and localization because 
it requires fixation.
Figure 5 | The principle of MALDI imaging. Thin slices of tissue samples are attached to the 
MALDI (matrix-assisted laser desorption/ionization)-sample plate and coated with a MALDI 
matrix. A MALDI-time-of-flight (TOF) instrument is then used to acquire mass spectra in a 
dense pattern on the sample surface. The spatial resolution, which is limited by the diameter 
of the desorption/ionization laser, approaches 1 pixel per µm. Similar to the way that a picture 
produced by an optical scanner consists of pixels, each of which is assigned an intensity 
value, the mass spectrometric image also consists of pixels, each of which represents one 
mass spectrum. By assigning different colours to selected mass (m)-to-charge (z) values, 
the mass spectrometric image can be used to visualize the spatial distribution of selected 
compounds in the tissue studied. Modified, with permission, from Nature Medicine REF. 113 © 
(2001) Macmillan Magazines Ltd.
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ENZYMELINKED 
IMMUNOSORBENT ASSAY
(ELISA). A widely used 
immunochemical method 
for detecting antigens or 
antibodies. ELISA methods are 
carried out in microtitre plates 
and use colorimetric detection. 
PEPTIDE NUCLEIC ACID 
A biopolymer molecule 
that consists of DNA bases 
connected by a backbone 
of peptide bonds, rather 
than phosphodiester bonds 
as in natural DNA. 
SIZEEXCLUSION 
CHROMATOGRAPHY 
This method makes use of the 
different chromatographical 
behaviour that depends on the 
size of molecules and partly 
on their shape. The extent of 
the size exclusion of molecules 
is determined by the steric 
hindrance of analyte molecules 
that is due to matrix substance. 
Small molecules can more 
or less access the interior of 
the matrix, whereas large 
molecules pass by the matrix. 
ELECTROSPRAY IONIZATION 
An ionization technique that is 
suitable for mass spectrometric 
analysis of large biomolecules. 
The sample, dissolved in an 
aqueous-organic solvent, 
is pumped through a fine 
capillary that is made of 
electrically conductive material. 
The high voltage that is applied 
results in the emission of an 
aerosol of charged droplets 
of the analyte solution. 
Using heated gas, the spray is 
directed through a series of 
chambers that have successively 
decreased pressures, which 
results in the formation of 
gas-phase analyte ions.
A more direct approach takes advantage of GFP 
reporter proteins and is able to monitor protein localiza-
tion through real-time detection108,109. Reporter proteins 
can be cloned in a genomic library for protein expres-
sion110, and the location of the GFP-tagged proteins in 
a cell can be detected by fluorescence microscopy. A 
proteome-wide approach has already been performed 
in yeast by Huh et al.111 who studied over 6,000 pro-
teins using GFP reporters. In mammalian, plant and 
Drosophila melanogaster cells, systematic GFP-based 
localization studies are also under way112. Although GFP 
technology is useful for the systematic characterization 
of protein localization and dynamics, antibody-based 
approaches will remain valuable tools; for example, for 
the study of protein expression for clinical applications.
MALDI time-of-flight (TOF) imaging mass spec-
trometry, as illustrated in FIG. 5, is an emerging technique 
for the spatial and quantitative analysis of biomolecules in 
cell or tissue extracts113. Modern MALDI mass spectrom-
eters are equipped with all the necessary components for 
this technique including imaging software (for example, 
see the Bruker Daltonics web site in the Online links 
box). This technique is currently used to map the distri-
bution of selected compounds in a tissue113. The tissues 
under investigation contain well-defined regions, many 
of which have been shown to contain subsets of proteins 
and peptides that occur in a characteristic distribution.
New directions in diagnostic protein detection. 
Proteins in biological samples cannot be amplified. 
The transformation of protein information to DNA 
molecules, however, is a new way to amplify this 
information for detection. RCA, which produces a 
long DNA molecule that contains hundreds of copies 
of circular DNA sequences, can be used as a powerful 
approach to detect proteins at high sensitivities114. For 
example, oligonucleotides that provide templates for 
signal amplification by RCA can be attached to capture 
molecules such as antibodies.
Proximity ligation is a promising method115,116 that 
uses pairs of protein binders that are tagged with DNA 
strands, in close proximity to a single-target molecule or 
molecular complex. The free ends of these DNA mol-
ecules are ligated in a proximity-dependent reaction on 
a complementary template DNA, so that the captured 
protein can be identified by a tag sequence. The sensitiv-
ity that is due to local signal amplification is high enough 
to detect single reacted probe pairs by microscopy. 
Proximity ligation has important advantages, including 
the high dynamic range that is achievable in detec-
tion and the highly specific analysis that is due to the 
simultaneous detection of a target molecule by two or 
more binders. Moreover, several protein epitopes can be 
independently identified, which is an important step in 
the analysis of secondary modifications. Finally, reagents 
that do not bind to a target molecule generate almost no 
detectable non-specific background. Unfortunately, the 
development of suitable binder pairs has not yet been 
automated and represents a bottleneck in the production 
of new proximity-ligation probes.
Low-density electrical biochips that combine sili-
con technology with microfluidics and biochemistry 
Box 2 | Detection devices for miniaturized systems 
Indirect methods that require fluorescent labelling for detection, or direct methods such as electrochemistry and mass 
spectrometry, have so far mainly been used in biology122.
Fluorescence-based detection is used to analyse single molecules at a high geometrical resolution (in the range of 
~500 nm). Although fluorescence detection on surfaces allows high throughput, owing to rapid parallel read-out, 
the small number of detection channels is the main limitation of this method. The simultaneous analysis of up to 
8 detection channels in a laser-scanning microscope is now possible owing to the recent development of adjustable 
acoustic optic tunable filters (for example, from Leica Microsystems), and the use of efficient algorithms (for 
example, the LSM 510 META from Zeiss AG) to separate dyes that have overlapping emission spectra. This allows the 
parallel detection of up to 8 GFPs.
The introduction of two ionization techniques, electrospray ionization mass spectrometry132,133 and matrix-assisted 
laser desorption/ionization134,135 in the mid-1980s, allowed the mass analysis of large biomolecules and initiated 
the rapid development of mass spectrometry to become a key analytical technique in the life sciences. Developments 
in instrument design have reduced the detection limit for proteins and peptides to attomole levels and has also 
improved the accuracy of mass determination in the low ppm range. New methods for fragmentation analysis 
have helped to determine structural features, such as amino-acid sequences and protein post-translational 
modifications.
Electrical detection allows single-molecule analysis to be carried out at a high resolution117. Industrial 
standards such as large-scale production and quality control are the main advantages of these approaches. 
Electrochemical analysis is, in principle, cheap and does not need any mechanical adjustment, as is needed in 
optical detection. Optical and mass spectrometric detection require more sophisticated and expensive devices 
and are likely to be used as complementary methods when carrying out high-throughput experiments. Electrical 
devices allow for extensive miniaturization and construction of small portable instruments that might be used 
for sensitive and specific detection of biomarkers in the future. Emerging nanomechanical and nanoelectronic 
detectors can provide direct, highly sensitive, real-time analysis of genes, mRNAs and proteins136–138. New 
fabrication methods and integration with miniaturized and automated microfluidics are prerequisites for these 
instruments that will probably revolutionize data analysis and acquisition over the next several years. Their 
application will focus on the routine quantitative analysis of single cells for protein–protein, protein–DNA and 
protein–small molecule binding events.
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represent another approach117, which has been used to 
detect complexes that consist, for example, of proteins 
and small molecules. Biochips that are based on silicon 
technology allow high spatial resolution and direct signal 
transfer from a sensing element to a transducer. Silicon-
based electrical biochips have been developed and use 
redox-recycling reactions on interdigitated ultramicro-
electrodes that are arranged in array formats118. Binding 
events can be monitored by redox-recycling of products, 
which is generated through enzyme labelling of affin-
ity complexes119. The principles of this method can be 
extended to other formats such as integrated ‘lab-on-a-
chip’ devices or metal nanoparticles. Low-density electri-
cal biochips will probably become routine instruments 
for diagnostics, provided that the market situation will 
allow their launch.
Outlook
Many biomolecules have to be analysed to investi-
gate complex biological systems. Although a limited 
number of key factors of biological relevance might 
be sufficient to provide predictive models120, marker 
molecules have to be analysed in many samples for 
potential diagnosis and drug development121. Real 
progress in the diagnosis and therapy of almost all 
complex diseases requires the identification and in-
depth analysis of many, if not all, components that 
influence these biological processes.
Similar to information technology, miniaturization 
has revolutionized biology. New hardware components 
for liquid handling and sensitive detection devices 
have helped the development of efficient and sensitive 
high-throughput methods that provide more experi-
mental data for biological problem-solving BOX 2. 
Several simple in vitro methods, such as oligonucle-
otide hybridization, have been miniaturized using 
microarray formats and are now routinely applied. 
However, new concepts are required not only for 
high-throughput sequencing, but also for many other 
purposes, which have been outlined in this article. 
Methods to specifically detect individual biomolecules 
at the level of populations and within and among cells 
are difficult to achieve. At present, only a few molecules 
can be identified and analysed at the single-molecule 
level in complex mixtures.
A further problem concerns data handling. Molecular 
data sets such as gene-expression profiles can be pro-
duced in a relatively short time. However, the lack of 
standardization of data between laboratories is obvious. 
Data standardization is required for consistent analysis of 
different biological data sets that are stored in databases. 
Currently, the first efforts are being made to structure 
the heterogeneous data obtained from high-throughput 
experiments from many laboratories. Agreements on 
standardization, as well as creating interconnected data-
bases, are essential prerequisites for the efficient analysis 
of molecular networks. Initiatives have been launched to 
standardize the bioinformatic treatment of microarray 
data interpretation (for example, the MIAME (mini-
mum information about a microarray experiment) and 
MAGE (microarray and gene expression) initiatives; see 
the Microarray Gene Expression Data Society web site in 
the Online links box), which will probably be adopted for 
experimentation and database handling in the future.
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